Comprehensive review on ultrasound-responsive theranostic nanomaterials: mechanisms, structures and medical applications

• Sepand Tehrani Fateh,
• Lida Moradi,
• Elmira Kohan,
• Michael R. Hamblin and
• Amin Shiralizadeh Dezfuli

Beilstein J. Nanotechnol. 2021, 12, 808–862, doi:10.3762/bjnano.12.64

Uniform Fe₃O₄/Gd₂O₃-DHCA nanocubes for dual-mode magnetic resonance imaging

• Miao Qin,
• Yueyou Peng,
• Mengjie Xu,
• Hui Yan,
• Yizhu Cheng,
• Xiumei Zhang,
• Di Huang,
• Weiyi Chen and
• Yanfeng Meng

Beilstein J. Nanotechnol. 2020, 11, 1000–1009, doi:10.3762/bjnano.11.84

• distributed Fe3O4/Gd2O3 nanocubes for T1–T2 dual-mode MRI contrast agents were successfully designed and synthesized. In order to increase hydrophilicity and biocompatibility, the nanocubes were coated with nontoxic 3,4-dihydroxyhydrocinnamic acid (DHCA). The results show that iron (Fe) and gadolinium (Gd

• researchers have been developing strategies to synthesize contrast agents [6][7][8][9]. MRI contrast agents can interact with the hydrogen protons that are present in the surrounding tissue, shortening their relaxation times and leading to signal changes [10]. Generally, contrast agents can be divided into

• Fe3O4 nanoparticles have been extensively investigated as MRI contrast agents due to their biocompatibility, many recent studies concerning T1–T2 dual-mode contrast agents use Fe3O4 nanoparticles [22]. For example, Zhou et al. [23] demonstrated that uniformly distributed Gd-embedded Fe3O4 nanoparticles

Key for crossing the BBB with nanoparticles: the rational design

• Sonia M. Lombardo,
• Marc Schneider,
• Akif E. Türeli and
• Nazende Günday Türeli

Beilstein J. Nanotechnol. 2020, 11, 866–883, doi:10.3762/bjnano.11.72

• brain delivery. Interestingly, in a study by Peira et al., SLNs have been successfully loaded with superparamagnetic iron oxide and were able to cross the BBB [163]. Thus, SLNs could be potentially used as carriers for CNS MRI contrast agents. Nanostructured lipid carriers: Although most of the reported

• ) are based on magnetite (Fe3O4) or maghemite (γ-Fe2O3) molecules encapsulated in polysaccharides, synthetic polymers or monomer coatings and have a size range from 1 to 100 nm [21][182]. SPIONs possess interesting magnetic properties and some formulations have already been approved as MRI contrast

• agents for imaging of the liver by the Food and Drug Administration (FDA) [183]. However, these formulations are no longer available because of concerns about toxicity and fatal anaphylactic reactions. Nowadays, ferumoxytol is the only SPION formulation approved by the FDA for human use, under the

Multilayer capsules made of weak polyelectrolytes: a review on the preparation, functionalization and applications in drug delivery

• Varsha Sharma and
• Anandhakumar Sundaramurthy

Beilstein J. Nanotechnol. 2020, 11, 508–532, doi:10.3762/bjnano.11.41

Nitrogen-vacancy centers in diamond for nanoscale magnetic resonance imaging applications

• Alberto Boretti,
• Lorenzo Rosa,
• Jonathan Blackledge and
• Stefania Castelletto

Beilstein J. Nanotechnol. 2019, 10, 2128–2151, doi:10.3762/bjnano.10.207

• monitoring intracellular processes relevant in biological and medical applications. In this context, hybrid systems using NV sensors with other MRI contrast agents or sensors have been proposed such as iron oxide nanoparticles and paramagnetic gadolinium complexes. SPIONs are single-domain magnetic systems

Gold-coated plant virus as computed tomography imaging contrast agent

• Alaa A. A. Aljabali,
• Mazhar S. Al Zoubi,
• Khalid M. Al-Batanyeh,
• Ali Al-Radaideh,
• Mohammad A. Obeid,
• Abeer Al Sharabi,
• Walhan Alshaer,
• Bayan AbuFares,
• Tasnim Al-Zanati,
• Murtaza M. Tambuwala,
• Naveed Akbar and
• David J. Evans

Beilstein J. Nanotechnol. 2019, 10, 1983–1993, doi:10.3762/bjnano.10.195

• toxicity, biocompatibility, immunogenicity, distribution and the payload being carried. Modified protein cages are robust systems that combine imaging capabilities and target selectivity on the same platform. One application is the development of magnetic resonance imaging (MRI) contrast agents. Current

Magnetic properties of biofunctionalized iron oxide nanoparticles as magnetic resonance imaging contrast agents

• Natalia E. Gervits,
• Andrey A. Gippius,
• Alexey V. Tkachev,
• Evgeniy I. Demikhov,
• Sergey S. Starchikov,
• Igor S. Lyubutin,
• Alexander L. Vasiliev,
• Vladimir P. Chekhonin,
• Maxim A. Abakumov,
• Alevtina S. Semkina and
• Alexander G. Mazhuga

Beilstein J. Nanotechnol. 2019, 10, 1964–1972, doi:10.3762/bjnano.10.193

• spectroscopy; MRI contrast agents; nanocrystalline materials; NMR spectroscopy; Raman spectroscopy; Introduction Nowadays, magnetic nanoparticles (MNPs) are widely used in biology and medicine. A large number of studies [1][2][3][4] have shown different prospects of their use for sample preparation, in

• genomic and proteomic analysis [5], for drug delivery [6], as magnetic resonance imaging (MRI) contrast agents [7], and for magnetic hyperthermia [8]. This wide variety of applications is due to the unique combination of magnetic, optical and chemical properties that are characteristic of MNPs. However

• article is to investigate the crystal structure and magnetic properties of iron oxide nanoparticles, which have already been proven to be effective as MRI contrast agents as studied by different techniques, including XRD, Mössbauer, Raman and 57Fe NMR spectroscopy. The question of the effect of the type

Scavenging of reactive oxygen species by phenolic compound-modified maghemite nanoparticles

• Małgorzata Świętek,
• Yi-Chin Lu,
• Rafał Konefał,
• Liliana P. Ferreira,
• M. Margarida Cruz,
• Yunn-Hwa Ma and
• Daniel Horák

Beilstein J. Nanotechnol. 2019, 10, 1073–1088, doi:10.3762/bjnano.10.108

• , targeting tumor sites using an external magnetic field, MRI contrast agents, or magnetic hyperthermia. Under physiological conditions, the nanoparticle surface is exposed to the action of biomolecules, oxygen, peroxides, and radicals, which changes particle properties and behavior. Moreover, Fe2+ ions can

Polydopamine-coated Au nanorods for targeted fluorescent cell imaging and photothermal therapy

• Boris N. Khlebtsov,
• Andrey M. Burov,
• Timofey E. Pylaev and
• Nikolai G. Khlebtsov

Beilstein J. Nanotechnol. 2019, 10, 794–803, doi:10.3762/bjnano.10.79

• . Meanwhile different imaging and therapeutic agents can be loaded into the shell of multifunctional nanocomposites. Various AuNR-based nanocomposites loaded with anticancer drugs [17][18][19], photodynamic dyes [20][21], MRI contrast agents [22] and many others ligands [23][24] have already been reported for

Cytotoxicity of doxorubicin-conjugated poly[N-(2-hydroxypropyl)methacrylamide]-modified γ-Fe₂O₃ nanoparticles towards human tumor cells

• Zdeněk Plichta,
• Yulia Kozak,
• Rostyslav Panchuk,
• Viktoria Sokolova,
• Matthias Epple,
• Lesya Kobylinska,
• Pavla Jendelová and
• Daniel Horák

Beilstein J. Nanotechnol. 2018, 9, 2533–2545, doi:10.3762/bjnano.9.236

• from MRI contrast agents to drug-delivery systems, local heat sources in magnetic hyperthermia therapy of tumors, magnetically assisted transfection of cells, and magnetic field-assisted separation techniques. Let us to note that MRI is already widely used in human medicine and several iron-oxide-based

Synthesis and functionalization of NaGdF₄:Yb,Er@NaGdF₄ core–shell nanoparticles for possible application as multimodal contrast agents

• Dovile Baziulyte-Paulaviciene,
• Vitalijus Karabanovas,
• Marius Stasys,
• Greta Jarockyte,
• Vilius Poderys,
• Simas Sakirzanovas and
• Ricardas Rotomskis

Beilstein J. Nanotechnol. 2017, 8, 1815–1824, doi:10.3762/bjnano.8.183

• may yield reduced values for MR signal enhancement [29][30]. These observations indicate that both core and core–shell UCNPs could be applied as efficient MRI contrast agents as they both present enhanced MR signal intensity. The as-prepared Tween 80-coated core–shell NaGdF4:Yb,Er@NaGdF4 nanoparticles

Multiwalled carbon nanotube hybrids as MRI contrast agents

• Nikodem Kuźnik and
• Mateusz M. Tomczyk

Beilstein J. Nanotechnol. 2016, 7, 1086–1103, doi:10.3762/bjnano.7.102

• functionalization and the potential to penetrate cell membranes result in a unique and very attractive candidate for a new MRI contrast agent. In this review we describe the different issues connected with MWCNT hybrids designed for MRI contrast agents, i.e., their synthesis and magnetic and dispersion properties

• problems here and support them with the available relaxation theories and the associating factors which may be helpful in designing new and even better models of MWCNT MRI CAs. Review 1 Specificity of MWCNT hybrids for the use as MRI contrast agents Synthesis MWCNTs were synthesized by chemical catalytic

• h period of measurement. 2 The use of MWCNT hybrids as MRI contrast agents Mechanistic considerations Magnetic resonance imaging is based on the phenomenon of nuclear magnetic resonance [48]. There are nuclides of non-zero nuclear spins. 1H is the most important representative of this group due to

Thermal treatment of magnetite nanoparticles

• Beata Kalska-Szostko,
• Urszula Wykowska,
• Dariusz Satula and
• Per Nordblad

Beilstein J. Nanotechnol. 2015, 6, 1385–1396, doi:10.3762/bjnano.6.143

• their application in various fields. The list of possible applications encompasses biomedical engineering, MRI contrast agents, hyperthermia treatment, sensing and biosensing [2][3]. They are also very promising candidates for electrical-related applications, for example, energy and magnetic storage

Silica micro/nanospheres for theranostics: from bimodal MRI and fluorescent imaging probes to cancer therapy

• Shanka Walia and
• Amitabha Acharya

Beilstein J. Nanotechnol. 2015, 6, 546–558, doi:10.3762/bjnano.6.57

• oxide or lanthanide complexes as magnetic and ruthenium or lanthanide complexes as fluorescent probe Superparamagnetic iron oxide NPs have been widely studied as MRI contrast agents for biological systems. These are less toxic compared to their chelated lanthanide counterparts. Again, because of the

Inorganic Janus particles for biomedical applications

• Isabel Schick,
• Steffen Lorenz,
• Dominik Gehrig,
• Stefan Tenzer,
• Wiebke Storck,
• Karl Fischer,
• Dennis Strand,
• Frédéric Laquai and
• Wolfgang Tremel

Beilstein J. Nanotechnol. 2014, 5, 2346–2362, doi:10.3762/bjnano.5.244

• magnetic nanoparticles in the late 1970’s for the first time [83]. Nowadays, superparamagnetic iron oxide nanoparticle-based MRI contrast agents are used in clinical applications [84]. Further, iron oxide based nanoparticles are in focus of research for their application as MRI contrast agents, including

• resonance and their additional strong contrast for CT-analysis, which enables dual detection for in vivo analysis. Furthermore, the materials of the metal oxide domain were chosen to exhibit magnetic behavior to be able to apply the multifunctional Janus particles as MRI contrast agents. As long term

Magnetic nanoparticles for biomedical NMR-based diagnostics

• Huilin Shao,
• Tae-Jong Yoon,
• Monty Liong,
• Ralph Weissleder and
• Hakho Lee

Beilstein J. Nanotechnol. 2010, 1, 142–154, doi:10.3762/bjnano.1.17

• ][21][22][23][24][25]. A variety of chemical methods, ranging from traditional wet chemistry to high-temperature thermal decomposition, have been employed to synthesize MNPs. Colloidal iron oxide nanoparticles, which are used as clinical magnetic resonance imaging (MRI) contrast agents, are generally